{"id": "chatcmpl-8JZmY5ldtgo1dasQUuRmCcq0dDdFH", "object": "chat.completion", "created": 1699676470, "model": "gpt-4-0613", "choices": [{"index": 0, "message": {"role": "assistant", "content": "1. The study or observation was conducted at Week 8.\n2. CKD-828 2.5/40 mg showed superior BP-lowering effects to S-amlodipine 2.5 mg.\n3. CKD-828 2.5/80 mg showed superior BP-lowering effects to S-amlodipine 2.5 mg.\n4. The superiority of CKD-828 2.5/40 mg over S-amlodipine 2.5 mg was statistically significant with P<0.001.\n5. The superiority of CKD-828 2.5/80 mg over S-amlodipine 2.5 mg was statistically significant with P<0.001.\n6. The sitDBP/SBP for CKD-828 2.5/40 mg was statistically significant with P=0.0002/P<0.0001.\n7. The sitDBP/SBP for CKD-828 2.5/80 mg was statistically significant with P=0.0001/P<0.0001."}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 122, "completion_tokens": 227, "total_tokens": 349}, "temperature": 0, "max_tokens": 512, "top_p": 1, "frequency_penalty": 0, "presence_penalty": 0, "messages": [{"role": "system", "content": "Statement: At Week 8, the CKD-828 2.5/40 mg (sitDBP/SBP: P=0.0002/P<0.0001) and CKD-828 2.5/80 mg (sitDBP/SBP: P=0.0001/P<0.0001) showed superior BP-lowering effects to S-amlodipine 2.5 mg (P<0.001).\n\nList all the facts we explicitly know from the statement. Make each fact as atomic as possible."}]}